Regeneron Pharmaceuticals (0R2M.L) Stock Price
$564.7 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
6 -
Technical
5
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Regeneron Pharmaceuticals, AI stock picks, stock alerts and much more.
0R2M.L AI Stock Analysis
AI stock analysis for 0R2M.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Regeneron Pharmaceuticals (0R2M.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Regeneron Pharmaceuticals (0R2M.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Regeneron Pharmaceuticals (0R2M.L), currently trading at $564.7, will... Sign up to access price prediction.
About 0R2M.L
-
Regeneron Pharmaceuticals, Inc.
-
Symbol
0R2M.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
58.8B
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$394.5 0.3% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$142.1 0.9% |
6 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$8.23 1.5% |
5 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$6.64 2.1% |
5 |
 |
Esperion Therapeutics 0IIM.L |
$2.8 2.9% |
6 |
News
0R2M.L Alternative Data
Web Traffic
Regeneron Pharmaceuticals receives an estimated 345436 monthly visitors to regeneron.com, which is down by -7.4% over the last month.
-
Web Traffic
345436
-
Change from Previous Month
7.4%
-
3 Month Change
8%
-
YoY Change
8%
Twitter Followers
Regeneron Pharmaceuticals has 33,433 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.3% over the last month.
-
Twitter Followers
33433
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
0.7%
-
YoY Change
0.7%
TikTok Followers
Regeneron Pharmaceuticals has 2,135 TikTok Followers on its main TikTok account, down by -0.5% over the last month.
-
TikTok Followers
2135
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
1.8%
-
YoY Change
1.8%
Facebook Engagement
Regeneron Pharmaceuticals has engaged 2,167 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
2167
-
Daily Change
10.1%
-
1 Month Change
127.9%
-
3 Month Change
93.7%
-
YoY Change
93.7%
Instagram Followers
Regeneron Pharmaceuticals has 16,774 Instagram Followers on its main Instagram account, up by 1% over the last month.
-
Instagram Followers
16774
-
Daily Change
0%
-
1 Month Change
1%
-
3 Month Change
2.6%
-
YoY Change
2.6%
Youtube Subscribers
Regeneron Pharmaceuticals has 2,370 subscribers on its main Youtube channel, up by 1.7% over the last month.
-
Youtube Subscribers
2370
-
Daily Change
0%
-
1 Month Change
1.7%
-
3 Month Change
3.5%
-
YoY Change
3.5%
Job Postings
Regeneron Pharmaceuticals currenly has an estimated 291 open job postings, up by 5.8% over the last month.
-
Job Postings
291
-
Daily Change
0%
-
1 Month Change
5.8%
-
3 Month Change
5.2%
-
YoY Change
5.2%
Reddit Mentions
Regeneron Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
569,964 are following Regeneron Pharmaceuticals on LinkedIn, up by 1.6% over the last month.
-
LinkedIn Followers
569964
-
Daily Change
1.6%
-
1 Month Change
1.6%
-
3 Month Change
4.8%
-
YoY Change
4.8%
Business Outlook
According to employee reviews, the business outlook among employees at Regeneron Pharmaceuticals is 68 out of 100 (bullish), down by -2.9% over the last month.
-
Business Outlook
68
-
Change from Previous Month
2.9%
-
3 Month Change
5.6%
-
YoY Change
5.6%
LinkedIn Employees
According to LinkedIn, Regeneron Pharmaceuticals has 16,435 employees, up by 0% over the last month.
-
LinkedIn Employees
16435
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
2.9%
-
YoY Change
2.9%
News Mentions
Regeneron Pharmaceuticals was mentioned 2 times in the news yesterday.
-
News Mentions
2
-
Daily Change
50%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0R2M.L Financials
0R2M.L Key Metrics
-
Total Revenue
$3B
-
Net Income
$808.7M
-
Earnings per Share
$7.58
-
Free cash flow
$773.6M
-
EBITDA
$1B
-
EBITDA Ratio
0.34358
-
Total Assets
$37.5B
0R2M.L 2-year Revenue & Income
0R2M.L 2-year Free Cash Flow
0R2M.L Technicals
0R2M.L SMA
0R2M.L RSI
FAQ
What's the current price of Regeneron Pharmaceuticals (0R2M.L) Stock?
The price of an Regeneron Pharmaceuticals (0R2M.L) share is $564.7.
What's the market cap of Regeneron Pharmaceuticals?
The current market cap of Regeneron Pharmaceuticals is 58.8B.
What are some stocks similar to Regeneron Pharmaceuticals (0R2M.L) that investors often compare it to?
Regeneron Pharmaceuticals (0R2M.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Esperion Therapeutics.
What is the forecast for Regeneron Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Regeneron Pharmaceuticals' stock price to be around $585.8 in 2026. Starting from the current price of $564.7, this represents a 3.7% change in price, indicating a neutral outlook for the stock.
How to buy Regeneron Pharmaceuticals (0R2M.L) Stock?
Regeneron Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Regeneron Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.